
American biotech firm, Myriad Genetics, Inc., develops and markets diagnostic products for early disease detection and prevention.
Myriad Genetics, Inc. is an American biotechnology company focused on developing and marketing molecular diagnostic products. Their core mission is to provide physicians with critical information to guide patient care, prevent disease, delay its onset, and catch it early. Myriad offers a range of genetic tests that provide individualized insights for better detection, treatment, and prevention of diseases, making healthcare more personal and precise.
Myriad Genetics has achieved significant milestones in the field of molecular diagnostics, contributing to advancements in personalized medicine. Their genetic tests have been instrumental in transforming patient care by enabling early disease detection and tailored treatment plans. The company's impact is evident in its role in improving health outcomes through innovative genetic insights.
Companies similar to Myriad Genetics include Invitae, 23andMe, GeneDx Holdings and Iverson Genetic Diagnostics.
Myriad Genetics was founded in 1991.
Myriad Genetics' headquarters is located in Salt Lake City, UT, US.
Myriad Genetics' most recent funding round was for $90M (USD) in July 2023.
As of Jul 6, 2023, Myriad Genetics has disclosed funding of $90M (USD). Undisclosed round amounts are excluded.
Myriad Genetics has 2,600 employees as of Feb 6, 2024.

Invitae
invitae.com

23andMe
23andme.com

GeneDx Holdings
genedx.com

Iverson Genetic Diagnostics

Ovagene Oncology
Enzo Biochem

Geneicd

HTG Molecular Diagnostics
htgmolecular.com

Juno Diagnostics

Genendeavor
genendeavor.com

Fulgent Genetics

Color
color.com

NeoGenomics Laboratories
neogenomics.com

Geneticure
geneticure.com

Amplified Sciences